People with HIV hospitalized less often since combination antiretroviral drug therapy introduced

December 17, 2012

TORONTO, Dec. 17, 2012--People with HIV are being hospitalized in Ontario significantly less often than they were 15 years ago when combination antiretroviral drug therapy (cART) was introduced, new research has found.

However, women with HIV are still hospitalized more than men with HIV as are low-income people with HIV compared with high-income people with HIV, according to a study by Tony Antoniou, a pharmacist and researcher in the Department of Family Medicine at St. Michael's Hospital.

Immigrants with HIV who had been in Ontario three years or less had lower rates of hospital admissions than Canadian-born people with HIV or immigrants who had been in Ontario longer than three years.

His study was conducted using data at the Institute for Clinical Evaluative Sciences (ICES) and appears in the online journal Open Medicine.Combination antiretroviral drug therapy, introduced in 1996-97, involves the use of three or more drugs to lower the amount of HIV in the body and prevent the progression of AIDS and death.

"Although our study is overall a 'good news' story for persons with HIV in Ontario, the differences in rates of hospitalization over the past decade suggest that women and low-income individuals living with HIV may face challenges accessing medication and community-based care," said Dr. Antoniou.

While rates of all hospital admissions among all persons with HIV in Ontario declined by about 2 per cent per year between 2002 and 2008, rates in women and low-income persons with HIV were 15 per cent and 21 per cent higher than those of men and high-income patients, respectively, during this period. In addition, rates of hospital admission attributable to HIV itself were 30 per cent higher in low-income persons with HIV relative to high-income persons.

Dr. Antoniou said he believes that universal access to life-saving anti-HIV treatments would be one way to address these disparities, but that, "We need to do more research to understand and address the root causes of these differences, to ensure that all persons with HIV are able to benefit equally from the advances that have been made in managing this illness."
-end-
About St. Michael's Hospital

St. Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in more than 23 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, and care of the homeless are among the Hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Center, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

For more information or to interview Dr. Antoniou, please contact:

Leslie Shepherd
Manager, Media Strategy
St. Michael's Hospital
Phone: 416-864-6094 or 647-300-1753
shepherdl@smh.ca

or

Kate Taylor
Communications Adviser
St. Michael's Hospital
Phone: 416-864-6060 x. 6537
TaylorKa@smh.ca

Inspired Care. Inspiring Science
www.stmichaelshospital.com

St. Michael's Hospital

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.